• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

橄榄苦苷 Gnetin H 是一种新型糖酵解抑制剂,可调节硫氧还蛋白相互作用蛋白的表达,并与癌细胞中的 OXPHOS 抑制剂协同作用。

The Oligostilbene Gnetin H Is a Novel Glycolysis Inhibitor That Regulates Thioredoxin Interacting Protein Expression and Synergizes with OXPHOS Inhibitor in Cancer Cells.

机构信息

National Center for Natural Products Research, Research Institute of Pharmaceutical Sciences, School of Pharmacy, University of Mississippi, University, MS 38677, USA.

Cancer Center & Research Institute, Department of Pharmacology & Toxicology, School of Medicine, University of Mississippi Medical Center, Jackson, MS 39216, USA.

出版信息

Int J Mol Sci. 2023 Apr 23;24(9):7741. doi: 10.3390/ijms24097741.

DOI:10.3390/ijms24097741
PMID:37175448
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10178141/
Abstract

Since aerobic glycolysis was first observed in tumors almost a century ago by Otto Warburg, the field of cancer cell metabolism has sparked the interest of scientists around the world as it might offer new avenues of treatment for malignant cells. Our current study claims the discovery of gnetin H (GH) as a novel glycolysis inhibitor that can decrease metabolic activity and lactic acid synthesis and displays a strong cytostatic effect in melanoma and glioblastoma cells. Compared to most of the other glycolysis inhibitors used in combination with the complex-1 mitochondrial inhibitor phenformin (Phen), GH more potently inhibited cell growth. RNA-Seq with the T98G glioblastoma cell line treated with GH showed more than an 80-fold reduction in thioredoxin interacting protein (TXNIP) expression, indicating that GH has a direct effect on regulating a key gene involved in the homeostasis of cellular glucose. GH in combination with phenformin also substantially enhances the levels of p-AMPK, a marker of metabolic catastrophe. These findings suggest that the concurrent use of the glycolytic inhibitor GH with a complex-1 mitochondrial inhibitor could be used as a powerful tool for inducing metabolic catastrophe in cancer cells and reducing their growth.

摘要

自一个世纪前奥托·瓦尔堡(Otto Warburg)首次在肿瘤中观察到有氧糖酵解以来,癌细胞代谢领域引起了全世界科学家的兴趣,因为它可能为恶性细胞提供新的治疗途径。我们目前的研究声称发现了具有 novel glycolysis inhibitor 特性的染料木素 H(GH),它可以降低代谢活性和乳酸合成,并在黑色素瘤和神经胶质瘤细胞中显示出强烈的细胞生长抑制作用。与大多数与线粒体复合物 1 抑制剂苯乙双胍(Phen)联合使用的其他糖酵解抑制剂相比,GH 更能强烈抑制细胞生长。用 GH 处理 T98G 神经胶质瘤细胞系的 RNA-Seq 显示,硫氧还蛋白相互作用蛋白(TXNIP)的表达减少了 80 多倍,表明 GH 对调节与细胞葡萄糖内稳态相关的关键基因有直接作用。GH 与苯乙双胍联合使用还显著增加了 p-AMPK 的水平,这是代谢灾难的一个标志。这些发现表明,同时使用糖酵解抑制剂 GH 和线粒体复合物 1 抑制剂可以作为一种在癌细胞中诱导代谢灾难并减少其生长的强大工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49a5/10178141/aefff755c720/ijms-24-07741-g008a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49a5/10178141/ccc91388b1fe/ijms-24-07741-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49a5/10178141/fa534ba5594b/ijms-24-07741-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49a5/10178141/d80109b2a264/ijms-24-07741-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49a5/10178141/1feadc991ec6/ijms-24-07741-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49a5/10178141/3b086a4a37f2/ijms-24-07741-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49a5/10178141/d4cbd21e553b/ijms-24-07741-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49a5/10178141/bfea16b3011a/ijms-24-07741-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49a5/10178141/aefff755c720/ijms-24-07741-g008a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49a5/10178141/ccc91388b1fe/ijms-24-07741-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49a5/10178141/fa534ba5594b/ijms-24-07741-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49a5/10178141/d80109b2a264/ijms-24-07741-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49a5/10178141/1feadc991ec6/ijms-24-07741-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49a5/10178141/3b086a4a37f2/ijms-24-07741-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49a5/10178141/d4cbd21e553b/ijms-24-07741-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49a5/10178141/bfea16b3011a/ijms-24-07741-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49a5/10178141/aefff755c720/ijms-24-07741-g008a.jpg

相似文献

1
The Oligostilbene Gnetin H Is a Novel Glycolysis Inhibitor That Regulates Thioredoxin Interacting Protein Expression and Synergizes with OXPHOS Inhibitor in Cancer Cells.橄榄苦苷 Gnetin H 是一种新型糖酵解抑制剂,可调节硫氧还蛋白相互作用蛋白的表达,并与癌细胞中的 OXPHOS 抑制剂协同作用。
Int J Mol Sci. 2023 Apr 23;24(9):7741. doi: 10.3390/ijms24097741.
2
Genetic disruption of lactate/H+ symporters (MCTs) and their subunit CD147/BASIGIN sensitizes glycolytic tumor cells to phenformin.基因敲除乳酸/H+转运蛋白(MCTs)及其亚基 CD147/BASIGIN 可使糖酵解肿瘤细胞对苯乙双胍敏感。
Cancer Res. 2015 Jan 1;75(1):171-80. doi: 10.1158/0008-5472.CAN-14-2260. Epub 2014 Nov 17.
3
2-Deoxyglucose induces the expression of thioredoxin interacting protein (TXNIP) by increasing O-GlcNAcylation - Implications for targeting the Warburg effect in cancer cells.2-脱氧葡萄糖通过增加O-连接的N-乙酰葡糖胺化诱导硫氧还蛋白相互作用蛋白(TXNIP)的表达——对靶向癌细胞中瓦伯格效应的意义
Biochem Biophys Res Commun. 2015 Oct 2;465(4):838-44. doi: 10.1016/j.bbrc.2015.08.097. Epub 2015 Aug 24.
4
TXNIP Links Anticipatory Unfolded Protein Response to Estrogen Reprogramming Glucose Metabolism in Breast Cancer Cells.TXNIP 将未折叠蛋白反应与雌激素重编程乳腺癌细胞的葡萄糖代谢联系起来。
Endocrinology. 2022 Jan 1;163(1). doi: 10.1210/endocr/bqab212.
5
Molecular biological investigation of temozolomide and KC7F2 combination in U87MG glioma cell line.替莫唑胺与 KC7F2 联合对 U87MG 脑胶质瘤细胞系的分子生物学研究。
Gene. 2021 Apr 15;776:145445. doi: 10.1016/j.gene.2021.145445. Epub 2021 Jan 21.
6
Enhanced Sensitivity of Nonsmall Cell Lung Cancer with Acquired Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors to Phenformin: The Roles of a Metabolic Shift to Oxidative Phosphorylation and Redox Balance.表皮生长因子受体酪氨酸激酶抑制剂获得性耐药的非小细胞肺癌对苯乙双胍敏感性增强:代谢向氧化磷酸化和氧化还原平衡转变的作用。
Oxid Med Cell Longev. 2021 Jul 29;2021:5428364. doi: 10.1155/2021/5428364. eCollection 2021.
7
Lactic acid induces lactate transport and glycolysis/OXPHOS interconversion in glioblastoma.乳酸诱导脑胶质瘤中乳酸转运和糖酵解/氧化磷酸化的转换。
Biochem Biophys Res Commun. 2018 Sep 5;503(2):888-894. doi: 10.1016/j.bbrc.2018.06.092. Epub 2018 Jun 21.
8
Myc-Driven Glycolysis Is a Therapeutic Target in Glioblastoma.Myc驱动的糖酵解是胶质母细胞瘤的一个治疗靶点。
Clin Cancer Res. 2016 Sep 1;22(17):4452-65. doi: 10.1158/1078-0432.CCR-15-2274. Epub 2016 Apr 13.
9
Metabolic reprogramming in cancer cells: glycolysis, glutaminolysis, and Bcl-2 proteins as novel therapeutic targets for cancer.癌细胞中的代谢重编程:糖酵解、谷氨酰胺分解以及Bcl-2蛋白作为癌症的新型治疗靶点
World J Surg Oncol. 2016 Jan 20;14(1):15. doi: 10.1186/s12957-016-0769-9.
10
Disruption of BASIGIN decreases lactic acid export and sensitizes non-small cell lung cancer to biguanides independently of the LKB1 status.BASIGIN的破坏会减少乳酸输出,并使非小细胞肺癌对双胍类药物敏感,且与LKB1状态无关。
Oncotarget. 2015 Mar 30;6(9):6708-21. doi: 10.18632/oncotarget.2862.

引用本文的文献

1
Extraction, purification, in vitro antioxidant and cytoprotective ability of oligostilbenes from paeonia seeds threshing residues.芍药种子脱粒残渣中低聚芪类化合物的提取、纯化、体外抗氧化及细胞保护能力
PLoS One. 2025 Jun 11;20(6):e0325485. doi: 10.1371/journal.pone.0325485. eCollection 2025.
2
The role of glycolysis in tumorigenesis: From biological aspects to therapeutic opportunities.糖酵解在肿瘤发生中的作用:从生物学角度到治疗机会。
Neoplasia. 2024 Dec;58:101076. doi: 10.1016/j.neo.2024.101076. Epub 2024 Oct 30.
3
Progress in antitumor mechanisms and applications of phenformin (Review).

本文引用的文献

1
Inhibits Cancer Proliferation in Signaling Pathways of 12 Reporter Genes.抑制 12 个报告基因信号通路中的癌症增殖。
Int J Mol Sci. 2023 Jan 6;24(2):1139. doi: 10.3390/ijms24021139.
2
Glycolytic Inhibitors Potentiated the Activity of Paclitaxel and Their Nanoencapsulation Increased Their Delivery in a Lung Cancer Model.糖酵解抑制剂增强了紫杉醇的活性,并且它们的纳米包封提高了其在肺癌模型中的递送。
Pharmaceutics. 2022 Sep 23;14(10):2021. doi: 10.3390/pharmaceutics14102021.
3
Autoregulation of H/lactate efflux prevents monocarboxylate transport (MCT) inhibitors from reducing glycolytic lactic acid production.
二甲双胍抗肿瘤机制及应用的研究进展(综述)。
Oncol Rep. 2024 Nov;52(5). doi: 10.3892/or.2024.8810. Epub 2024 Sep 20.
4
Cysteine protease inhibitor 1 promotes metastasis by mediating an oxidative phosphorylation/MEK/ERK axis in esophageal squamous carcinoma cancer.半胱氨酸蛋白酶抑制剂 1 通过介导食管鳞癌细胞的氧化磷酸化/MEK/ERK 轴促进转移。
Sci Rep. 2024 Feb 29;14(1):4985. doi: 10.1038/s41598-024-55544-1.
5
Cell Metabolism Therapy by Small Natural Compounds.小分子天然化合物的细胞代谢治疗。
Int J Mol Sci. 2023 Sep 7;24(18):13776. doi: 10.3390/ijms241813776.
自调节 H/乳酸外排可防止单羧酸转运蛋白(MCT)抑制剂减少糖酵解产生的乳酸。
Br J Cancer. 2022 Oct;127(7):1365-1377. doi: 10.1038/s41416-022-01910-7. Epub 2022 Jul 15.
4
Oxamate targeting aggressive cancers with special emphasis to brain tumors.靶向侵袭性癌症,特别关注脑肿瘤的草氨酸盐。
Biomed Pharmacother. 2022 Mar;147:112686. doi: 10.1016/j.biopha.2022.112686. Epub 2022 Feb 4.
5
Regulation of reverse electron transfer at mitochondrial complex I by unconventional Notch action in cancer stem cells.线粒体复合物 I 中的逆向电子转移受癌症干细胞中非传统 Notch 作用的调节。
Dev Cell. 2022 Jan 24;57(2):260-276.e9. doi: 10.1016/j.devcel.2021.12.020.
6
The Epithelial-Mesenchymal Transition at the Crossroads between Metabolism and Tumor Progression.上皮-间充质转化在代谢与肿瘤进展的交汇点。
Int J Mol Sci. 2022 Jan 12;23(2):800. doi: 10.3390/ijms23020800.
7
Metabolic reprogramming in cervical cancer and metabolomics perspectives.宫颈癌中的代谢重编程及代谢组学视角
Nutr Metab (Lond). 2021 Oct 19;18(1):93. doi: 10.1186/s12986-021-00615-7.
8
Metformin and Dichloroacetate Suppress Proliferation of Liver Cancer Cells by Inhibiting mTOR Complex 1.二甲双胍和二氯乙酸通过抑制 mTOR 复合物 1 抑制肝癌细胞增殖。
Int J Mol Sci. 2021 Sep 17;22(18):10027. doi: 10.3390/ijms221810027.
9
Cisplatin Resistance and Redox-Metabolic Vulnerability: A Second Alteration.顺铂耐药性与氧化还原代谢脆弱性:第二个改变。
Int J Mol Sci. 2021 Jul 9;22(14):7379. doi: 10.3390/ijms22147379.
10
The Warburg effect as a therapeutic target for bladder cancers and intratumoral heterogeneity in associated molecular targets.沃伯格效应作为膀胱癌的治疗靶点及相关分子靶点的肿瘤内异质性。
Cancer Sci. 2021 Sep;112(9):3822-3834. doi: 10.1111/cas.15047. Epub 2021 Jul 12.